Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA approves Thoratec's portable VAD (ventricular assist device) driver:

This article was originally published in Clinica

Executive Summary

The US FDA has approved Thoratec's PMA supplement application for its TLC-II portable ventricular assist device (VAD) driver. Weighing just 20lbs (9.1kgs), the device is the only one of its kind that can provide left, right or biventricular support to patients awaiting heart transplantation or recovering from open-heart surgery, says its Pleasanton, California manufacturer. Under the new approval, the VAD driver can be used to allow certain patients to take off-site excursions within a two-hour travel radius of the hospital in the company of a trained caregiver. Thoratec is also evaluating the device for use in patients discharged from hospital to their homes (see Clinica No 934, p 17).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel